Alimera Sciences
ALIM
ALIM was delisted on the 13th of September, 2024.
30 hedge funds and large institutions have $146M invested in Alimera Sciences in 2023 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and closing their positions.
71,004% more capital inflows, than outflows
Capital inflows: $145M | Capital outflows: $204K
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
67% more funds holding
Funds holding: 18 → 30 (+12)
42.75% more ownership
Funds ownership: 47.41% → 90.16% (+43%)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Caligan Partners
New York
|
+$54.1M |
| 2 |
Velan Capital Investment Management
Alpharetta,
Georgia
|
+$39.5M |
| 3 |
Stonepine Capital Management
Bend,
Oregon
|
+$13.2M |
| 4 |
Boothbay Fund Management
New York
|
+$10.6M |
| 5 |
ACM
Altium Capital Management
New York
|
+$9.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bridgeway Capital Management
Houston,
Texas
|
-$60.5K |
| 2 |
Renaissance Technologies
New York
|
-$55.6K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$39.2K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$24.8K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$21.5K |
ALIM Hedge Fund Activity: Q3 2023 in Review
30 of the 6,317 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q3 2023, worth a combined $146M — up 1,328% from $10.3M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new ALIM positions and 0 closed out — a net gain of 12 holders — while 5 added to existing stakes and 7 trimmed.
The largest buyer was Caligan Partners, adding an estimated $54.1M. The largest seller was Bridgeway Capital Management, cutting an estimated $60.5K.
- 30 institutional investors held Alimera Sciences (ALIM) as of Q3 2023, up from 18 in Q2 2023.
- Funds reported $146M of Alimera Sciences stock for Q3 2023, up 1,328% quarter-over-quarter.
- 12 funds opened new Alimera Sciences positions in Q3 2023 and 0 closed out, a net change of +12 holders.
- The largest Alimera Sciences buyer in Q3 2023 was Caligan Partners, an estimated $54.1M added.
- The largest Alimera Sciences seller in Q3 2023 was Bridgeway Capital Management, an estimated $60.5K sold.
Based on aggregated 13F filings for Q3 2023.